Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the effectiveness of a posterior hip capsule block performed in addition to a PENG (Pericapsular Nerve Group) block for patients undergoing hip arthroplasty. The primary objective is to assess whether this combined approach provides enhanced perioperative analgesia compared to the standard analgesic protocol or the PENG block alone. Secondary outcomes will focus on opioid consumption, functional recovery, and any potential complications. By targeting both the anterior and posterior innervation pathways around the hip joint, this combined technique could improve patient comfort, decrease opioid requirements, and potentially expedite rehabilitation after hip arthroplasty.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DPPG compartment block | Experimental | Deep posterior post gluteal compartment block with different volume of product 5,10 and 15 ml (local anesthetics such as naropeine 0.35%) to compare the efficiency of the block without sciatic nerve block effect |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Deep posterior post gluteal nerve block | Procedure | One injection with ultrasound guidance injection of 5, 10 or 15 mL of naropeine 0.35 % Procedure : injection below the piriformis muscle in front of the head of the femur. |
| Measure | Description | Time Frame |
|---|---|---|
| Sciatic nerve block | number of patients with postoperative sciatic motor or sensitory nerve block collected by clinical examination (test with hot and cold in the sciatic territory and motricity of the feet) | From enrollment to the end of treatment at 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Pain postoperative | Visual analogic pain (VAS) AT 6 hours 0 : no pain 10: maximum pain | From enrollment to the end of treatment at 1 MONTH |
| pain 2 | Visual analogic pain (VAS) AT 12 hours 0 : no pain 10: maximum pain |
Not provided
Inclusion Criteria:
All adults with total hip arthroplasty
-
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| YOANN ELMALEH, M.D | Contact | +33781330431 | Yoyo.elmaleh@hotmail.fr |
| Name | Affiliation | Role |
|---|---|---|
| yoann ELMALEH, M.D | Hopital Privé Claude Galien | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38764441 | Background | Pun M, Ng T, Vermeylen K, Tran J. Innervation of the hip joint: implications for regional anaesthesia and image-guided interventional pain procedures. BJA Educ. 2024 Jun;24(6):191-202. doi: 10.1016/j.bjae.2024.02.005. Epub 2024 Apr 8. No abstract available. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| From enrollment to the end of treatment at 1 MONTH |
| oPIOID Consumption | Opioid consumption per and postoperative until 48 hours | From enrollment to the end of treatment at 7 months |
| RAAC | QOR15 scale at H24 and H48 questionnaire with 15 questions from 0 to 10 (https://pqip.org.uk/FilesUploaded/Myles%20QoR-15.pdf) | From enrollment to the end of treatment at 1 MONTH |
| Surgical complication | Surgical postoperative complication or fall | From enrollment to the end of treatment at 1 MONTH |